Demonstrates thymosin β4 reduces senescence of circulating endothelial progenitor cells (EPCs) via the PI3K/Akt/eNOS signaling pathway. TB4 treatment of cultured EPCs decreased β-galactosidase senescence markers and extended functional proliferative capacity; PI3K/Akt and eNOS inhibitors blocked this effect. Establishes TB4 as an anti-senescence agent for EPCs—extending cellular healthspan beyond the limited replicative lifespan of untreated EPCs—with implications for improving autologous EPC therapy in elderly patients whose cells have reduced regenerative capacity.
Li, Juan; Yu, Lu; Zhao, Yanbo; Fu, Guosheng; Zhou, Binquan